CryoPort (CYRX) Competitors $8.69 -0.08 (-0.91%) Closing price 04:00 PM EasternExtended Trading$8.83 +0.14 (+1.66%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYRX vs. DYN, APGE, TWST, BEAM, CDTX, IMCR, BHVN, WVE, AUPH, and TVTXShould you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Dyne Therapeutics (DYN), Apogee Therapeutics (APGE), Twist Bioscience (TWST), Beam Therapeutics (BEAM), Cidara Therapeutics (CDTX), Immunocore (IMCR), Biohaven (BHVN), WAVE Life Sciences (WVE), Aurinia Pharmaceuticals (AUPH), and Travere Therapeutics (TVTX). These companies are all part of the "pharmaceutical products" industry. CryoPort vs. Its Competitors Dyne Therapeutics Apogee Therapeutics Twist Bioscience Beam Therapeutics Cidara Therapeutics Immunocore Biohaven WAVE Life Sciences Aurinia Pharmaceuticals Travere Therapeutics Dyne Therapeutics (NASDAQ:DYN) and CryoPort (NASDAQ:CYRX) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings. Do analysts rate DYN or CYRX? Dyne Therapeutics currently has a consensus target price of $34.07, indicating a potential upside of 147.76%. CryoPort has a consensus target price of $12.00, indicating a potential upside of 38.09%. Given Dyne Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Dyne Therapeutics is more favorable than CryoPort.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dyne Therapeutics 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 3 Strong Buy rating(s) 3.06CryoPort 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, DYN or CYRX? CryoPort has higher revenue and earnings than Dyne Therapeutics. Dyne Therapeutics is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDyne TherapeuticsN/AN/A-$317.42M-$3.86-3.56CryoPort$228.38M1.91-$114.76M$1.336.53 Which has more volatility and risk, DYN or CYRX? Dyne Therapeutics has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500. Does the media refer more to DYN or CYRX? In the previous week, Dyne Therapeutics had 13 more articles in the media than CryoPort. MarketBeat recorded 17 mentions for Dyne Therapeutics and 4 mentions for CryoPort. Dyne Therapeutics' average media sentiment score of 1.17 beat CryoPort's score of 1.03 indicating that Dyne Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dyne Therapeutics 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CryoPort 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of DYN or CYRX? 96.7% of Dyne Therapeutics shares are owned by institutional investors. Comparatively, 92.9% of CryoPort shares are owned by institutional investors. 14.1% of Dyne Therapeutics shares are owned by insiders. Comparatively, 10.0% of CryoPort shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is DYN or CYRX more profitable? CryoPort has a net margin of 37.21% compared to Dyne Therapeutics' net margin of 0.00%. CryoPort's return on equity of -9.79% beat Dyne Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Dyne TherapeuticsN/A -64.12% -56.75% CryoPort 37.21%-9.79%-5.42% SummaryDyne Therapeutics and CryoPort tied by winning 8 of the 16 factors compared between the two stocks. Get CryoPort News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoPortTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$439.09M$5.58B$7.31B$9.80BDividend YieldN/A2.36%949.34%4.02%P/E Ratio6.5310.9314.5926.59Price / Sales1.911.03474.44173.43Price / CashN/A11.127.9859.36Price / Book0.912.792.196.68Net Income-$114.76M$184.49M$571.12M$265.59M7 Day Performance2.24%3.22%2.65%3.42%1 Month Performance13.59%-1.91%1.08%1.09%1 Year Performance-0.46%-4.88%9.46%23.84% CryoPort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoPort3.7357 of 5 stars$8.69-0.9%$12.00+38.1%-0.7%$439.09M$228.38M6.531,186Positive NewsDYNDyne Therapeutics3.5786 of 5 stars$13.00+3.3%$34.07+162.1%-69.0%$1.79BN/A-3.37100Positive NewsAnalyst UpgradeAPGEApogee Therapeutics3.7515 of 5 stars$36.94-3.5%$99.00+168.0%-20.5%$1.76BN/A-8.9491Positive NewsAnalyst ForecastTWSTTwist Bioscience4.0393 of 5 stars$27.39-4.2%$49.40+80.4%-39.7%$1.73B$312.97M-18.89990Positive NewsBEAMBeam Therapeutics2.046 of 5 stars$16.44-1.2%$48.45+194.7%-35.9%$1.68B$60.27M-3.65510Positive NewsCDTXCidara Therapeutics3.6222 of 5 stars$64.13-3.4%$64.14+0.0%+404.2%$1.68B$1.27M-5.7690Positive NewsIMCRImmunocore1.5813 of 5 stars$32.59-1.0%$56.89+74.6%-9.7%$1.66B$310.20M-81.48320Positive NewsAnalyst ForecastBHVNBiohaven3.8071 of 5 stars$14.96-4.2%$54.23+262.5%-62.3%$1.65BN/A-1.95239WVEWAVE Life Sciences4.7744 of 5 stars$9.94-2.1%$20.27+103.9%+78.4%$1.62B$108.30M-11.04240Insider TradeAUPHAurinia Pharmaceuticals2.2545 of 5 stars$12.14-1.1%$12.00-1.2%+79.9%$1.62B$235.13M28.23300Positive NewsTVTXTravere Therapeutics2.351 of 5 stars$17.23-3.9%$32.21+87.0%+92.5%$1.60B$233.18M-8.45460Positive NewsAnalyst ForecastGap Up Related Companies and Tools Related Companies Dyne Therapeutics Competitors Apogee Therapeutics Competitors Twist Bioscience Competitors Beam Therapeutics Competitors Cidara Therapeutics Competitors Immunocore Competitors Biohaven Competitors WAVE Life Sciences Competitors Aurinia Pharmaceuticals Competitors Travere Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYRX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoPort, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoPort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access